Neuroprotective Therapies for Patients With Worsening Glaucoma Despite Adequate Intraocular Pressure Lowering-Short-term Neurorecovery, Long-term Neuroprotection?
- PMID: 34792548
- DOI: 10.1001/jamaophthalmol.2021.4573
Neuroprotective Therapies for Patients With Worsening Glaucoma Despite Adequate Intraocular Pressure Lowering-Short-term Neurorecovery, Long-term Neuroprotection?
Comment in
-
Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial.JAMA Ophthalmol. 2022 Jan 1;140(1):11-18. doi: 10.1001/jamaophthalmol.2021.4576. JAMA Ophthalmol. 2022. PMID: 34792559 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical